Medindia

X

EntreMed Reports First Quarter 2011 Financial Results

Monday, May 16, 2011 General News J E 4
Advertisement

ENTREMED, INC.

SUMMARY OF OPERATING RESULTS

Three Months Ended

March 31,

2011

2010

Total revenues

$0

$0

Research and development

$1,398,274

$843,953

General and administrative

$1,253,105

$1,051,225

Net Loss

$(2,596,379)

$(2,126,144)

Net loss per share attributable to common shareholders (basic and diluted)

$(0.25)

$(0.28)

Weighted average number of shares outstanding (basic and diluted)  

11,444,711

8,540,812

Cash and Short-term Investments

$4,828,893

$9,691,834

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Uroplasty to Issue Fourth Quarter and Full Fiscal ...
S
Mylan Launches First Generic Version of XibromŪ Op...